Collplant Biotechnologies logo

Collplant Biotechnologies Share Price (NASDAQ: CLGN)

$2.69

-0.08

(-2.89%)

Last updated on

Check the interactive Collplant Biotechnologies Stock chart to analyse performance

Collplant Biotechnologies stock performance

as on August 30, 2025 at 1:27 am IST

  • Today's Low:$2.60
    Today's High:$2.69

    Day's Volatility :3.35%

  • 52 Weeks Low:$1.31
    52 Weeks High:$5.45

    52 Weeks Volatility :75.96%

Collplant Biotechnologies Stock Returns

PeriodCollplant Biotechnologies LtdIndex (Russel 2000)
3 Months
14.04%
0.0%
6 Months
-23.53%
0.0%
1 Year
-50.57%
0.0%
3 Years
-65.88%
-4.1%

Collplant Biotechnologies Ltd Key Stats

Check Collplant Biotechnologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.77
Open
$2.6
Today's High
$2.69
Today's Low
$2.6
Market Capitalization
$33.3M
Today's Volume
$3.2K
52 Week High
$5.45
52 Week Low
$1.31
Revenue TTM
$2.4M
EBITDA
$-12.4M
Earnings Per Share (EPS)
$-1.13
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-78.25%

Stock Returns calculator for Collplant Biotechnologies Stock including INR - Dollar returns

The Collplant Biotechnologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Collplant Biotechnologies investment value today

Current value as on today

₹56,425

Returns

₹43,575

(-43.58%)

Returns from Collplant Biotechnologies Stock

₹48,859 (-48.86%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Collplant Biotechnologies Stock

-38%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Collplant Biotechnologies Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Collplant Biotechnologies Ltd

  • Name

    Holdings %

  • Parallel Advisors, LLC

    0.03%

Analyst Recommendation on Collplant Biotechnologies Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Collplant Biotechnologies(by analysts ranked 0 to 5 stars)

Collplant Biotechnologies Share Price Target

What analysts predicted

Upside of 329.74%

Target:

$11.56

Current:

$2.69

Collplant Biotechnologies share price target is $11.56, a slight Upside of 329.74% compared to current price of $2.69 as per analysts' prediction.

Collplant Biotechnologies Stock Insights

  • Price Movement

    In the last 7 days, CLGN stock has moved up by 3.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 2.05M → 179.0K (in $), with an average decrease of 91.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.45M → -3.34M (in $), with an average decrease of 130.5% per quarter
  • CLGN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 120.8%
  • CLGN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 181.2%
  • Price to Sales

    ForCLGN every $1 of sales, investors are willing to pay $12.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Collplant Biotechnologies Ltd Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$515.0K
↓ 95.3%
Net Income
$-16.6M
↑ 136.63%
Net Profit Margin
-3.2K%
↓ 3161.0%

Collplant Biotechnologies Technicals Summary

Sell

Neutral

Buy

Collplant Biotechnologies is currently in a neutral trading position according to technical analysis indicators.

Collplant Biotechnologies Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Collplant Biotechnologies Ltd logo
13.51%
-23.53%
-50.57%
-65.88%
-70.95%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Collplant Biotechnologies Ltd

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound healing flowable gel for the treatment of chronic and acute wounds. The company also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. It has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Organization
Collplant Biotechnologies
Employees
57
CEO
Mr. Eran Rotem CPA
Industry
Health Technology

Key Management of Collplant Biotechnologies Ltd

NameTitle
Mr. Yehiel Tal
CEO & Director
Mr. Eran Rotem CPA
Deputy CEO & CFO
Mr. Oren Fahimipoor
Vice President of Operations
Dr. Elana Gazal
Vice President of Research & Development
Prof. Oded Shoseyov
Founder & Chief Scientist
Ms. Hadas Dreiher Horowitz
Vice President of Human Resources

Important FAQs about investing in CLGN Stock from India :

What is Collplant Biotechnologies share price today?

Collplant Biotechnologies share price today is $2.69 as on at the close of the market. Collplant Biotechnologies share today touched a day high of $2.69 and a low of $2.60.

What is the 52 week high and 52 week low for Collplant Biotechnologies share?

Collplant Biotechnologies share touched a 52 week high of $5.45 and a 52 week low of $1.31. Collplant Biotechnologies stock price today i.e. is closed at $2.69, lower by 50.64% versus the 52 week high.

How to invest in Collplant Biotechnologies Stock (CLGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Collplant Biotechnologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Collplant Biotechnologies Shares that will get you 0.5576 shares as per Collplant Biotechnologies share price of $2.69 per share as on August 30, 2025 at 1:27 am IST.

What is the minimum amount required to buy Collplant Biotechnologies Stock (CLGN) from India?

Indian investors can start investing in Collplant Biotechnologies (CLGN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Collplant Biotechnologies stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Collplant Biotechnologies share’s latest price of $2.69 as on August 30, 2025 at 1:27 am IST, you will get 3.7175 shares of Collplant Biotechnologies. Learn more about fractional shares .

What are the returns that Collplant Biotechnologies has given to Indian investors in the last 5 years?

Collplant Biotechnologies stock has given -70.95% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?